PersonBiotech
Chun‐Yao Huang
Author on Supporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseases.
Public external IDs
Source-confirmed affiliation
No reviewed public affiliation edge is attached.
Topics
Outputs
Supporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseasesSourceEuropean Organization for Nuclear ResearchSupporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseasesSourceEuropean Organization for Nuclear Research
Relationship evidence
Supporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseases
Supporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseases
Supporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseases
Supporting data and source files for: From publication concentration to clinical translation: a drug-indication evidence map of therapeutic FcRn inhibition across autoantibody-mediated diseases